Skye Bioscience, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -187 | -177 | -175 | |
EBITDA | -12,575 | -17,434 | -10,922 | -9,618 |
EBIT | -12,754 | -17,621 | -11,099 | -9,793 |
Net Income | -12,754 | -17,624 | -11,103 | -9,746 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -13,364 | -10,746 | -9,191,792 | -8,223 |
Cash | 18,441 | 23,838 | 46,421 | 68,415 |
Basic Shares | 39,665 | 39,659 | 39,652 | 39,969 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -298 | -124 | -114 | -34 |
EBITDA | -25,290 | -36,619 | -18,696 | -7,718 |
EBIT | -25,589 | -36,743 | -18,811 | -7,752 |
Net Income | -26,567 | -37,644 | -19,481 | -8,522 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -26,841 | -13,964 | -12,772 | -6,565 |
Cash | 68,415 | 1,256 | 1,244 | 8,983 |
Basic Shares | 36,486 | 7,006 | 493,654 | 1,626 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.32 |
2025-06-30 | -$0.44 |
2025-03-31 | -$0.28 |
2024-12-31 | -$0.29 |
